Previous close | 40.83 |
Open | 40.77 |
Bid | 41.03 x 100 |
Ask | 41.16 x 200 |
Day's range | 40.50 - 41.42 |
52-week range | 35.69 - 67.66 |
Volume | |
Avg. volume | 431,255 |
Market cap | 2.009B |
Beta (5Y monthly) | 0.84 |
PE ratio (TTM) | 15.81 |
EPS (TTM) | 2.60 |
Earnings date | 07 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 63.25 |
Amphastar Pharmaceuticals, Inc. ( NASDAQ:AMPH ) shareholders might be concerned after seeing the share price drop 26...
The latest trading day saw Amphastar Pharmaceuticals (AMPH) settling at $41.52, representing a -1% change from its previous close.
The average brokerage recommendation (ABR) for Amphastar (AMPH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?